RARE vs XTIA · rev $560.2M vs rev $3.2M
Ultragenyx (RARE) versus XTI Aerospace, Inc. (XTIA) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
XTI Aerospace, Inc. (XTIA) is a aerospace & defense company listed on NASDAQ.
Latest reported RARE revenue for 2024-12-31 was $560.2M. Net income was -$569.2M. Revenue was up 29.0% from 2023-12-31 to 2024-12-31. RARE currently screens at market cap $2.79B.
Latest reported XTIA revenue for 2024-12-31 was $3.2M. Net income was -$35.6M. Revenue was down 29.8% from 2023-12-31 to 2024-12-31. XTIA currently screens at market cap $69.3M.
RARE currently screens at market cap $2.79B. XTIA currently screens at market cap $69.3M.
Not investment advice. Open the RARE and XTIA stock pages for the full models.
Not investment advice.